Scilex Holding Company (SCLX)
NASDAQ · Healthcare
Scilex Holding Company EBITDA 2020–2025
Scilex Holding Company annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Scilex Holding Company ebitda for the quarter ending March 31, 2026 was -29.3 M, a 8.94% increase year-over-year.
- Scilex Holding Company ebitda for the twelve months ending March 31, 2026 was -99.1 M.
- Scilex Holding Company annual ebitda for 2025 was -341.4 M, a 330.23% increase from 2024.
- Scilex Holding Company annual ebitda for 2024 was -79.3 M, a 21.66% decrease from 2023.
- Scilex Holding Company annual ebitda for 2023 was -101.3 M, a 117.01% increase from 2022.
- Scilex Holding Company annual ebitda for 2022 was -46.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Scilex Holding Company EBITDA — FAQ
Scilex Holding Company (SCLX) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SCLX's ebitda history?
The chart and table above show Scilex Holding Company's ebitda by year and by quarter, including the growth rate.